The language of generalization.
Tessler MH, Goodman ND.
Psychol Rev. 2019 Apr;126(3):395-436. doi: 10.1037/rev0000142. Epub 2019 Feb 14.
Generically speaking.
[No authors listed]
Drug Ther Bull. 2009 Oct;47(10):109. doi: 10.1136/dtb.2009.09.0039.
Teleological generics.
Korman J, Khemlani S.
Cognition. 2020 Jul;200:104157. doi: 10.1016/j.cognition.2019.104157. Epub 2020 May 21.
Site-Specific and Country-of-Origin Labeling for Pharmaceutical Manufacturing.
Hatton RC, Leighton G, Englander L.
Ann Pharmacother. 2022 Oct;56(10):1184-1187. doi: 10.1177/10600280211069541. Epub 2022 Jan 13.
Robust morphogenesis by chaotic dynamics.
Reinitz J, Vakulenko S, Sudakow I, Grigoriev D.
Sci Rep. 2023 May 9;13(1):7482. doi: 10.1038/s41598-023-34041-x.
Tenders for generics and biosimilars: a challenging purchasing policy.
Antoñanzas F, Juárez-Castelló C, Rodríguez-Ibeas R.
Eur J Health Econ. 2023 Jun;24(4):485-487. doi: 10.1007/s10198-023-01580-z. Epub 2023 Mar 21.
Evergreened drugs or evergreened profits?
Siddalingaiah S, Fugh-Berman A.
J Eval Clin Pract. 2022 Dec;28(6):1119-1126. doi: 10.1111/jep.13695. Epub 2022 May 11.
More evidence, greater generalization? The relation between the prevalence of observed action and the strength of generalization depends on action properties.
Hu Y, Yang Y, Huang P, Ai D, Sun H, Zhou D, Huangliang J, Yin J.
J Exp Psychol Hum Percept Perform. 2023 Mar;49(3):306-326. doi: 10.1037/xhp0001097.
Non-Procrustean pathways for complex generic drugs development.
Cristofoletti R, Schmidt S, Diniz A.
Ther Deliv. 2018 Sep;9(9):605-607. doi: 10.4155/tde-2018-0047.
[Generic drugs controversy in oncology].
Levêque D, Becker G, Gourieux B.
Bull Cancer. 2017 Jun;104(6):497-499. doi: 10.1016/j.bulcan.2017.04.002. Epub 2017 May 8.
